Sales, marketing vet to lead TargetRx

Share this article:

Pharma sales service provider TargetRx has appointed industry sales and marketing veteran Craig Scott to the role of president and CEO. Scott also becomes a member of the company's board of directors.

Scott assumes the president and CEO role from Michael Luby, TargetRx founder who will remain a full-time employee of the company and a member of the board of directors.

Prior to joining TargetRx, Scott was president of the Catalina Health Resource division of Catalina Marketing Corporation from 2004 until the leveraged buyout of the company in November 2007.

During his tenure, Scott increased revenues and profits and led the transformation of Catalina Health Resource into a top provider of DTP communication services in pharmacies nationwide. Prior to Catalina, he was with Nelson Communications for nine years and Johnson & Johnson for 13 years.

At Johnson & Johnson, Scott held a variety of marketing and management positions.

“I am enthused by TargetRx's proprietary predictive modeling database,” Scott said. “With a comprehensive understanding of physician attitudes about products, promotion, payors and patients, we can offer pharmaceutical companies robust information that will fundamentally improve the effectiveness of their sales and marketing efforts. At this critical time for the industry, TargetRx will continue to provide clients with superior tools that will enable them to increase market share and improve the bottom line.” 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.